Innocoll is a privately held international biopharmaceutical company focused on targeted drug delivery primarily in the areas of biodegradable surgical implants and topically applied healthcare products.
We develop and manufacture a range of pharmaceutical products and medical devices using our proprietary collagen-based technologies, CollaRx®, CollaFilm™, CollaPress™ and LiquiColl®.
Our technologies are well established and are fully biocompatible and biodegradable with a long history of safe and effective use.
FEATURED PRODUCT 
COGENZIA®
Infected Diabetic Foot Ulcers are a significant unmet medical need.
FACT: 10% of Western Society is diabetic.
FACT: 15% of diabetics in Western Societies develop foot ulcers.
FACT: 50% of diabetic foot ulcers become infected.
FACT: Every 30 seconds a diabetic foot is amputated.
XARACOLL®
XaraColl is a surgical implant for the sustained delivery of bupivacaine hydrochloride.
XaraColl is intended to provide pain control directly at the surgical site and reduces the level of opioid analgesia required, following surgery.
COLLAGUARD®
CollaGUARD is a transparent bioresorbable film comprising of 100% type 1 collagen.
CollaGUARD is indicated for the prevention of postoperative adhesions in digestive, colorectal, gynecological, and urological surgery.
LATEST NEWS
GALLERY
